Reviewed profile

food and beverage brand · public preview

Dupixent

Retail brand

Public category
Retail brand
Brand tier
mainstream brand
Is this your company?Claim Dupixent to get found by buyers, add products and certifications, correct your details, and be eligible when Talio’s AI recommends suppliers.Let our AI make the introductionGet a warm, researched intro to Dupixent — no cold outreach.
Report a changeLog in for full recordLast reviewed 28 Mar 2026 · public preview data

Overview

What Dupixent covers.

Dupixent (dupilumab) is a prescription biologic medication used to treat several chronic inflammatory conditions. The approved indications include moderate-to-severe atopic dermatitis, asthma, chronic obstructive pulmonary disease (COPD), chronic rhinosinusitis with nasal polyps, and eosinophilic esophagitis, among others. The treatment is indicated for various patient populations ranging from infants six months and older to adults, depending on the specific condition being managed. Dupixent functions by targeting specific pathways involved in Type 2 inflammation.

  • Positioned as a mainstream brand.

FAQ

Questions this page answers.

What does Dupixent do?

Dupixent is a food and beverage brand, tracked in Talio's food and beverage intelligence platform.

Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

Own this company?

Get found by buyers — and the AI that recommends suppliers.

Claim this profile to appear in buyer searches, add your products and certifications, correct outdated details, and stay eligible when Talio's AI recommends suppliers.

Claiming grants reviewed submission rights only — not direct editing, suppression, or ownership of Talio-derived intelligence. Verification required.

Claim this pageLog in for full recordReport a change

Public preview data only · proprietary metrics remain in authenticated Talio.